![Philippe Durieux](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philippe Durieux
Président chez
CISSOID SA
Profil
Philippe Durieux is currently the Chief Executive Officer at Sopartec SA since 2006.
He is also the Chairman at CISSOID SA, Director at Xylowatt SA, Director at GreenWatt SA, and Director at Novadip Biosciences SA since 2017.
Previously, he worked as a Director at iTeos Therapeutics SA. Mr. Durieux completed his graduate degree at Hautes Etudes Commerciales and his undergraduate degree at Université Catholique de Louvain.
Postes actifs de Philippe Durieux
| Sociétés | Poste | Début |
|---|---|---|
Sopartec SA
 Sopartec SA Investment ManagersFinance Sopartec invests in companies located in Europe. The firm focuses on sectors such as life sciences, AgTech and hard engineering. It participates in seed, early and growth stage capital transactions with an investment size of EUR 0.1 - 7 million. The firm also acts as lead investor. | Private Equity Investor | 01/03/2024 |
CISSOID SA
 CISSOID SA Electrical ProductsProducer Manufacturing Manufactures industrial voltage regulators, oscillators and related electrical equipment | Président | - |
Novadip Biosciences SA
 Novadip Biosciences SA BiotechnologyHealth Technology Operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases | Directeur/Membre du Conseil | 30/05/2017 |
GreenWatt SA
 GreenWatt SA Electric UtilitiesUtilities Designs and installs on-site biomethanisation plants | Directeur/Membre du Conseil | - |
Anciens postes connus de Philippe Durieux
| Sociétés | Poste | Fin |
|---|---|---|
Xylowatt SA
 Xylowatt SA Electric UtilitiesUtilities Designs, develops and builds gasification reactors for energy conversion from biomass and waste products | Directeur/Membre du Conseil | 24/03/2021 |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology Engages in the discovery of immunomodulators for cancer therapy | Directeur/Membre du Conseil | - |
Formation de Philippe Durieux
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Hautes Etudes Commerciales
 Hautes Etudes Commerciales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sopartec SA
Sopartec SA Investment ManagersFinance Sopartec invests in companies located in Europe. The firm focuses on sectors such as life sciences, AgTech and hard engineering. It participates in seed, early and growth stage capital transactions with an investment size of EUR 0.1 - 7 million. The firm also acts as lead investor. | Finance |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CISSOID SA
CISSOID SA Electrical ProductsProducer Manufacturing Manufactures industrial voltage regulators, oscillators and related electrical equipment | Producer Manufacturing |
Xylowatt SA
Xylowatt SA Electric UtilitiesUtilities Designs, develops and builds gasification reactors for energy conversion from biomass and waste products | Utilities |
GreenWatt SA
GreenWatt SA Electric UtilitiesUtilities Designs and installs on-site biomethanisation plants | Utilities |
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology Engages in the discovery of immunomodulators for cancer therapy | Health Technology |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases | Health Technology |
